Morbidity and mortality following early administration of amiodarone in acute myocardial infarction

European Heart Journal

Volumn 21, Issue 3, 2000, Pages 198-205

  Elizari, M V ^a   Martinez J M ^b   Belziti, C ^c   Ciruzzi, M ^d   Perez De La Hoz R ^b   Sinisi, A ^e   Carbajales, J ^a   Scapin O ^a   Garguichevich, J ^f   Girotti, L ^a   Cagide, A ^c  

^a HOSPITAL RAMOS MEJÍA   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^d Hospital Pirovano   (Argentina)

^e Hospital Eva Peron   (Argentina)

^f HOSPITAL ESPAÑOL   (Argentina)

Author keywords

Acute myocardial infarction; Amiodarone; Mortality

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATLANSIL NR; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPOTENSION; HYPOTHYROIDISM; LIVER DYSFUNCTION; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0343750692     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1687     Document Type: Article

References (11)

1. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarction Survival (BASIS). J Am Coll Cardiol. 16:1990;1711-1718.
2. Ceremuzynski L, Kleczar E, Kreminska-Pakula M. Effect of amiodarone on mortality after myocardial infarction: a double blind, placebo-controlled, pilot study. J Am Coll Cardiol. 20:1992;1051-1062.
3. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet. 349:1997;675-682.
4. Julian DG, Camm AJ, Frangin G. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet. 349:1997;667-674.
5. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 344:1994;493-498.
6. Singh SN, Fletcher RD, Fisher SG. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 333:1995;77-82.
7. Schwartz A, Shen E, Morady F, Gillespie K, Scheinman M, Chatterjee K. Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia. Am Heart J. 106:1983;848-856.
8. Kosinski EJ, Albin JB, Young E, Lewis SM, LeLand S. Hemodynamic effects of intravenous amiodarone. J Am Coll Cardiol. 4:1984;565-570.
9. Remme WJ, Kruyssen HACM, Look MP, van Hoogenhuyze DCA, Krauss XH. Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function. Am Heart J. 122:1991;96-103.
10. Bashir Y, Sneddon JF, Paul VE. A prospective study of the efficacy and safety of adjuvant metroprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function. Am Heart J. 124:1992;1233-1244.
11. Lancet. 350:1997;1417-1424.